Document:

Form of Nonstatutory Stock Option Agreement (Employees)

 Exhibit 10.4 
  
 CENTENE CORPORATION 
  
 Nonstatutory Stock Option Agreement Granted Under  
 Amended and Restated 2003 Stock Incentive Plan 
  
 THIS AGREEMENT is entered into by and between CENTENE CORPORATION, a Delaware corporation (hereinafter the “Company”), and the undersigned employee of the Company (hereinafter the “Participant”).

  
 WHEREAS, the Participant renders important services to the
Company and acquires access to Confidential Information (as defined below) of the Company in connection with Participant’s relationship with the Company; and 
  
 WHEREAS, the Company desires to align the long-term interests of its valued employees with those of the Company by providing
the ownership interest granted herein and to prevent former employees whose interest may become adverse to the Company from maintaining an ownership interest in the Company; 
  
 NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby
agree as follows: 
  
 1. Grant of Option 
  
 This agreement evidences the grant by the Company on
             (the “Grant Date”) to      (the “Participant”), of an option to purchase, in whole or in part, on the terms provided
herein and in the Company’s Amended and Restated 2003 Stock Incentive Plan (the “Plan”), a total of              shares (the “Shares”) of common stock,
$0.001 par value per share, of the Company (“Common Stock”) at $             per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Central time, on
             (the “Final Exercise Date”). 
  
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code
of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant,” as used in this option, shall be deemed to include any person who acquires the
right to exercise this option validly under its terms. 
  
 2. Vesting
Schedule 
  
 This option will become exercisable
(“vest”) as to             % of the original number of Shares on the [            ] anniversary of the Grant
Date and as to an additional             % of the original number of Shares at the end of each successive
[                ] period following the first anniversary of the Grant Date until the [            ]
anniversary of the Grant Date. 
  
 The right of exercise shall be
cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final
Exercise Date or the termination of this option under Section 3 hereof or the Plan. 
  
 In the event of a “Change in Control” of the Company, all of the Shares that (but for the application of this clause) are not vested at the time of the occurrence of such Change in Control event shall vest.
A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Securities Exchange Act 

 
of 1934, as amended (the “Exchange Act”), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of
persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities representing forty percent or more of the combined voting power of the
Company’s then outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided,
however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board
shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of
Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a
merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or
consolidation. 
  
 3. Exercise of Option 
  
 (a) Form of Exercise. Each election to exercise this option shall be
in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. Common Stock purchased upon the exercise of this option shall be paid
for as follows 
  

	 	(1)	in cash or by check, payable to the order of the Company; 

  

	 	(2)	by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any
required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and
any required tax withholding; 

  

	 	(3)	when the Common Stock is registered under the Securities and Exchange Act of 1934, as amended, by delivery of shares of Common Stock owned by the Participant valued at their fair
market value as determined by (or in a manner approved by) the board of directors of the Company (the “Board”) in good faith (“Fair Market Value”), provided (i) such method of payment is then permitted under applicable law
and (ii) such Common Stock, if acquired directly from the Company was owned by the Participant at least six months prior to such delivery; 

  

	 	(4)	to the extent permitted under applicable law and permitted by the Board, in its sole discretion, provided that at least an amount equal to the par value of the Common Stock
being purchased shall be paid in cash; or 

  

	 	(5)	by any combination of the above permitted forms of payment. 

  
 The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional
share or for fewer than ten whole shares. 
  

 - 2 - 

 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this
Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor to, the Company or any
other entity the employees, officers, directors, consultants or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 
  
 (c) Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any
reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate 30 days after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable
only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality
provisions of any employment, consulting, advisory, nondisclosure, non-competition or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation. 
  
 (d) Exercise Period Upon Death or Disability. If the Participant dies
or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph
(e) below, this option shall be exercisable, within the period of 90 days following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall
be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 
  
 (e) Discharge for Cause. If the Participant, prior to the Final
Exercise Date, is discharged by the Company for “cause” (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such discharge. “Cause” shall mean willful misconduct by the
Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other agreement
between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant shall be considered to have been discharged for “cause” if the Company determines, within 30 days after the
Participant’s resignation, that discharge for cause was warranted. 
  
 (f) Right to Exercise. The Participant’s right to exercise this option and to retain any gains upon a sale or other disposition of the Shares therefrom is subject to the Participant’s compliance with the covenants set forth
in Section 4 hereof. 
  
 4. Optionee’s Covenants. For and in
consideration of the option hereunder, the Participant agrees to the provisions of this Section 4. 
  
 (a) Confidential Information. As used in this Section 4, “Confidential Information” shall mean the Company’s trade secrets and other
non-public proprietary information relating to the Company or the business of the Company, [including information relating to financial statements, existing or proposed target markets, employee skills and compensation, employee data, acquisition
targets, servicing methods, programs, strategies and information, analyses, expansion plans and strategies, profit margins, financial, promotional, training or operational information, and other information developed or used by the Company] that is
not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Participant. 
  

 - 3 - 

 (b) Non-Disclosure. The Participant agrees that the Confidential Information is a valuable,
special and unique asset of the Company’s business, that such Confidential Information is important to the Company and the effective operation of the Company’s business, and that during employment with the Company and at all times
thereafter, the Participant shall not, directly or indirectly, disclose to any competitor or other person or entity (other than current employees of the Company) any Confidential Information that the Participant obtains while performing services for
the Company, except as may be required in the Participant’s reasonable judgment to fulfill the Participant’s duties hereunder or to comply with any applicable legal obligation. 
  
 (c) Non-Competition; Non-Solicitation. 
  
 (1) During the Participant’s employment with the Company and for the period of six months immediately
after the termination of the Participant’s employment with the Company for any cause whatsoever, the Participant shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares),
counsel, advise, consult or be otherwise engaged or employed by any entity or enterprise (“Competitor”) that competes with (i) the Company’s business of providing Medicaid managed care services, Medicaid-related services, and behavior
health, nurse triage and pharmacy compliance specialty services or (ii) any other business in which, after the Grant Date, the Company becomes engaged (or has taken substantial steps in which to become engaged) on or prior to the date of termination
of the Participant’s employment, regarding which business the Participant has acquired confidential information, and regarding which business constitutes (or is expected to constitute if only then recently commenced) more than 5% of the annual
gross revenues of the Company or, as conducted by such Competitor, more than 35% of the Competitor’s annual gross revenues. 
  
 (2) During the Participant’s employment with the Company and for the period of twelve months immediately after the termination of the
Participant’s employment with the Company for any cause whatsoever (“Restricted Period”), the Participant will not, either directly or indirectly, either for the Participant or for any other person, firm, company or corporation, call
upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, vendors or suppliers of the Company that the Participant had dealings with, or responsibility for, or the
Participant had access to, confidential information of such customers, vendors or suppliers. 
  
 (3) The Participant shall not, at any time during the Restricted Period, without the prior written consent of the Company, (i) directly or
indirectly, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six months an employee, representative, officer or director of
the Company; or (ii) take any action to encourage or induce any employee, representative, officer or director of the Company to cease their relationship with the Company for any reason. 
  
 (d) Enforcement. If any of the provisions of this Section 4 shall be held to be invalid or unenforceable by a court
of competent jurisdiction, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 4 is held
to be overbroad or unreasonable as written, the parties agree that the applicable provision should be considered to be amended to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court and enforced as
amended. 
  

 - 4 - 

 (e) Remedy for Breach. 
  
 (1) Because the Participant’s services are unique and because the Participant has access to the
Company’s Confidential Information, the parties agree that any breach or threatened breach of this Section 4 will cause irreparable harm to the Company and that money damages alone would be an inadequate remedy. The parties therefore agree
that, in the event of any breach or threatened breach of this Section 4, and in addition to all other rights and remedies available to it, the Company may apply to any court of competent jurisdiction for specific performance and/or injunctive or
other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 4. 
  
 (2) The Participant acknowledges and agrees that nothing contained herein shall be construed to be an excessive remedy to prohibit the
Company from pursuing any other remedies available to it for such actual or threatened breach, including recovery of money damages, proximately caused by the Participant’s breach of this Section 4. 
  
 (f) Survival. The provisions of this Section 4 shall survive and
continue in full force in accordance with their terms notwithstanding any forfeiture, termination or expiration of this option in accordance with its terms or any termination of the Participant’s employment for any reason (whether voluntary or
involuntary). 
  
 5. Withholding 
  
 No Shares will be issued pursuant to the exercise of this option unless and
until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 
  
 6. Nontransferability of Option 
  
 This option may not be sold, assigned, transferred, pledged or otherwise
encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 
  
 7. Provisions of the Plan 
  
 This option is subject to the provisions of the Plan, a copy of which is
furnished to the Participant with this option. 
  

 - 5 - 

 IN WITNESS WHEREOF, the Company has caused this option to be
executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	 CENTENE CORPORATION

		
	 By:
	 	  

	 Name:
	 	 
	 Title
	 	 

  
 PARTICIPANT’S ACCEPTANCE 
  
 The undersigned
hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s Amended and Restated 2003 Stock Incentive Plan. 
  

					
	 	  	PARTICIPANT:
		
	Dated:                         	  	  

			
	 	  	Address:	  	  

	 	  	 	  	  

  

 - 6 -Form of Incentive Stock OPtion Agreement

 Exhibit 10.5 
  
 CENTENE CORPORATION 
  
 Incentive Stock Option Agreement Granted Under 
 Amended and Restated 2003 Stock Incentive Plan 
  
 THIS AGREEMENT is entered into by and between CENTENE CORPORATION, a Delaware corporation (hereinafter the “Company”), and the undersigned employee of the Company (hereinafter the “Participant”). 
  
 WHEREAS, the Participant renders important services to the Company and
acquires access to Confidential Information (as defined below) of the Company in connection with Participant’s relationship with the Company; and 
  
 WHEREAS, the Company desires to align the long-term interests of its valued employees with those of the Company by providing the ownership interest
granted herein and to prevent former employees whose interest may become adverse to the Company from maintaining an ownership interest in the Company; 
  
 NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:

  
 1. Grant of Option 
  
 This agreement evidences the grant by the Company, on
             (the “Grant Date”) to              (the “Participant”) of an option to purchase,
in whole or in part, on the terms provided herein and in the Company’s Amended and Restated 2003 Stock Incentive Plan (the “Plan”), a total of              shares (the
“Shares”) of common stock, $0.001 par value per share, of the Company (“Common Stock”) at $             per Share. Unless earlier terminated, this option shall
expire at 5:00 p.m., Central time, on              (the “Final Exercise Date”). 
  
 It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of
1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right
to exercise this option validly under its terms. 
  
 2. Vesting Schedule

  
 This option will become exercisable (“vest”) as to
            % of the original number of Shares on the [    ] anniversary of the Grant Date and as to an additional
            % of the original number of Shares at the end of each successive [    ] period following the first anniversary of the Grant Date until the
[    ] anniversary of the Grant Date. 
  
 The
right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until
the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan. 
  
 In the event of a “Change in Control” of the Company, all of the Shares that (but for the application of this clause) are not vested at the time
of the occurrence of such Change in Control event shall vest. A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of the 

 
following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act),
directly or indirectly, of securities representing forty percent or more of the combined voting power of the Company’s then outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company
(the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s
stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of
office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person
other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the
voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation. 
  
 3. Exercise of Option 
  
 (a) Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its
principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. Common Stock purchased upon the exercise of this option shall be paid for as follows 
  

	 	(1)	in cash or by check, payable to the order of the Company; 

  

	 	(2)	by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any
required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and
any required tax withholding; 

  

	 	(3)	when the Common Stock is registered under the Securities and Exchange Act of 1934, as amended, by delivery of shares of Common Stock owned by the Participant valued at their fair
market value as determined by (or in a manner approved by) the board of directors of the Company (the “Board”) in good faith (“Fair Market Value”), provided (i) such method of payment is then permitted under applicable law
and (ii) such Common Stock, if acquired directly from the Company was owned by the Participant at least six months prior to such delivery; 

  

	 	(4)	to the extent permitted under applicable law and permitted by the Board, in its sole discretion, provided that at least an amount equal to the par value of the Common Stock
being purchased shall be paid in cash; or 

  

	 	(5)	by any combination of the above permitted forms of payment. 

  
 The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any
fractional share or for fewer than ten whole shares. 
  

 - 2 - 

 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this
Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any parent or
subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 
  
 (c) Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided
in paragraphs (d) and (e) below, the right to exercise this option shall terminate 30 days after such cessation (but in no event after the Final Exercise Date), provided that this option shall be exercisable only to the extent that the
Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment
contract, confidentiality and nondisclosure agreement, other agreements between the Participant and the Company, including the confidentiality provisions of Section 4 of this Agreement, the right to exercise this option shall terminate immediately
upon such violation. 
  
 (d) Exercise Period Upon Death or
Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for
“cause” as specified in paragraph (e) below, this option shall be exercisable, within the period of 90 days following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized
transferee), provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be
exercisable after the Final Exercise Date. 
  
 (e) Discharge
for Cause. If the Participant, prior to the Final Exercise Date, is discharged by the Company for “cause” (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such discharge.
“Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including breach by the Participant of any provision of any employment, consulting,
advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant shall be considered to have been discharged for
“cause” if the Company determines, within 30 days after the Participant’s resignation, that discharge for cause was warranted. 
  
 (f) Right to Exercise. The Participant’s right to exercise this option and to retain any gains upon a sale or other disposition of the Shares
therefrom is subject to the Participant’s compliance with the covenants set forth in Section 4 hereof. 
  
 4. Optionee’s Covenants. For and in consideration of the option hereunder, the Participant agrees to the provisions of this Section 4. 
  
 (a) Confidential Information. As used in this Section 4, “Confidential Information” shall mean the
Company’s trade secrets and other non-public proprietary information relating to the Company or the business of the Company, including information relating to financial statements, customer lists and identities, potential customers, customer
contacts, employee skills and compensation, employee data, suppliers, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, profit margins, financial, promotional,
marketing, training or operational information, and other information developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain
or becomes known in the public domain through no wrongful act on the part of the Participant. 
  

 - 3 - 

 (b) Non-Disclosure. The Participant agrees that the Confidential Information is a valuable,
special and unique asset of the Company’s business, that such Confidential Information is important to the Company and the effective operation of the Company’s business, and that during employment with the Company and at all times
thereafter, the Participant shall not, directly or indirectly, disclose to any competitor or other person or entity (other than current employees of the Company) any Confidential Information that the Participant obtains while performing services for
the Company, except as may be required in the Participant’s reasonable judgment to fulfill his duties hereunder or to comply with any applicable legal obligation. 
  
 (c) Non-Competition; Non-Solicitation. 
  
 (1) During the Participant’s employment with the Company and for the period of six months immediately
after the termination of the Participant’s employment with the Company for any cause whatsoever, the Participant shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares),
counsel, advise, consult or be otherwise engaged or employed by any entity or enterprise (“Competitor”) that competes with (i) the Company’s business of providing Medicaid managed care services, Medicaid-related services, and behavior
health, nurse triage and pharmacy compliance specialty services or (ii) any other business in which, after the Grant Date, the Company becomes engaged (or has taken substantial steps in which to become engaged) on or prior to the date of termination
of the Participant’s employment, regarding which business the Participant has acquired confidential information, and regarding which business constitutes (or is expected to constitute if only then recently commenced) more than 5% of the annual
gross revenues of the Company or, as conducted by such Competitor, more than 35% of the Competitor’s annual gross revenues. 
  
 (2) During the Participant’s employment with the Company and for the period of twelve months immediately after the termination of the
Participant’s employment with the Company for any cause whatsoever (“Restricted Period”), the Participant will not, either directly or indirectly, either for himself or for any other person, firm, company or corporation, call upon,
solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, vendors or suppliers of the Company that the Participant had dealings with, or responsibility for, or the Participant
had access to, confidential information of such customers, vendors or suppliers. 
  
 (3) The Participant shall not, at any time during the Restricted Period, without the prior written consent of the Company, (i) directly or
indirectly, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six months an employee, representative, officer or director of
the Company; or (ii) take any action to encourage or induce any employee, representative, officer or director of the Company to cease their relationship with the Company for any reason. 
  
 (d) Enforcement. If any of the provisions or subparts of this Section 4 shall be held to be invalid or unenforceable
by a court of competent jurisdiction, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section
4 is held to be overbroad or unreasonable as written, the parties agree that the applicable provision should be considered to be amended to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court and
enforced as amended. 
  

 - 4 - 

 (e) Remedy for Breach. 
  
 (1) Because the Participant’s services are unique and because the Participant has access to the
Company’s Confidential Information, the parties agree that any breach or threatened breach of this Section 4 will cause irreparable harm to the Company and that money damages alone would be an inadequate remedy. The parties therefore agree
that, in the event of any breach or threatened breach of this Section 4, and in addition to all other rights and remedies available to it, the Company may apply to any court of competent jurisdiction for specific performance and/or injunctive or
other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 4. 
  
 (2) The Participant acknowledges and agrees that nothing contained herein shall be construed to be an excessive remedy to prohibit the
Company from pursuing any other remedies available to it for such actual or threatened breach, including but not limited to the recovery of money damages, proximately caused by the Participant’s breach of this Section 4. 
  
 (f) Survival. The provisions of this Section 4 shall survive and
continue in full force in accordance with their terms notwithstanding any forfeiture, termination or expiration of this option in accordance with its terms or any termination of the Participant’s employment for any reason (whether voluntary or
involuntary). 
  
 5. Tax Matters 
  
 (a) Withholding. No Shares will be issued pursuant to the exercise of
this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 
  
 (b) Disqualifying Disposition. If the Participant disposes of Shares
acquired upon exercise of this option within two years from the Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition. 
  
 6. Nontransferability of Option 
  
 This option may not be sold, assigned, transferred, pledged or otherwise
encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 
  
 7. Provisions of the Plan 
  
 This option is subject to the provisions of the Plan, a copy of which is
furnished to the Participant with this option. 
  

 - 5 - 

 IN WITNESS WHEREOF, the Company has caused this option to be
executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	 CENTENE CORPORATION

		
	 By:
	 	  

	 Name:
	 	 
	 Title
	 	 

  
 PARTICIPANT’S ACCEPTANCE 
  
 The undersigned
hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s 2003 Amended and Restated Stock Incentive Plan. 
  

					
	 	  	PARTICIPANT:
		
	Dated:                         	  	  

			
	 	  	Address:	  	  

	 	  	 	  	  

  

 - 6 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00088-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00088-of-00352.parquet"}]]